The market still sees the old Injective 👀
Across $HYPE and $ONDO attention tends to reward projects that can be understood through one dominant narrative, whether that is trading or tokenization.
I think this leaves a blind spot around ecosystems that have expanded beyond what they were originally known for, especially when the market continues evaluating them through an outdated identity.
Injective began with crypto-native markets, but it now combines that trading foundation with tokenized assets, institutional infrastructure, and a live U.S. ETF.
More than $12.8B traded through its onchain orderbook during the past year, showing that the original market engine remains active while the network expands into a much larger financial ecosystem.
The market may still remember Injective as an exchange-focused chain, but that description no longer captures what is being built.
This gap between perception and reality is why I believe Injective remains undervalued relative to its position in onchain finance 🔥
#Macro Insights#
Across $HYPE and $ONDO attention tends to reward projects that can be understood through one dominant narrative, whether that is trading or tokenization.
I think this leaves a blind spot around ecosystems that have expanded beyond what they were originally known for, especially when the market continues evaluating them through an outdated identity.
Injective began with crypto-native markets, but it now combines that trading foundation with tokenized assets, institutional infrastructure, and a live U.S. ETF.
More than $12.8B traded through its onchain orderbook during the past year, showing that the original market engine remains active while the network expands into a much larger financial ecosystem.
The market may still remember Injective as an exchange-focused chain, but that description no longer captures what is being built.
This gap between perception and reality is why I believe Injective remains undervalued relative to its position in onchain finance 🔥
#Macro Insights#
